eukaryotic translation initiation factor 2-alpha kinase 3; PRKR-like endoplasmic reticulum kinase; pancreatic eIF2-alpha kinase; HsPEK (EIF2AK3, PEK, PERK)
Jump to navigation
Jump to search
Function
- phosphorylates alpha subunit of eukaryotic translation- initiation factor 2 (eIF2)
- results in inactivation of eIF2
- rapid reduction of translational initiation
- repression of global protein synthesis
- effector of unfolded protein response
- induces G1 growth arrest due to the loss of cyclin D1
- forms dimers with HSPA5/BIP in resting cells
- dissociates from HSPA5/BIP & oligomerizes in ER-stressed cells
- interacts with DNAJC3
- autophosphorylated
Structure
- N-glycosylated
- the lumenal domain senses perturbations in protein folding in the ER, probably through reversible interaction with HSPA5/BIP
- belongs to the protein kinase superfamily, Ser/Thr protein kinase family, GCN2 subfamily
- contains 1 protein kinase domain
Compartment
Expression
Pathology
- defects are the cause of Wolcott-Rallison syndrome
- PERK is activated in the hippocampus of Alzheimer's disease patients & in the pons & medulla of patients with progressive supranuclear palsy[5]
Comparative biology
- in mice, PERK promotes misfolding and halts synthesis of specific proteins[2]
- inhibitor of PERK halts progression of prion disease in mice, but does not reverse deficits[2]
- inhibition of PERK or reduced expression of PERK improves long-term memory & behavioral plasticity in rats[3]*
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q9NZJ5.html
- ↑ 2.0 2.1 2.2 Moreno JA et al Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion- Infected Mice. Sci Transl Med. 2013 Oct 9;5(206):206ra138. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24107777 <Internet> http://stm.sciencemag.org/content/5/206/206ra138
- ↑ 3.0 3.1 University of Hafnia. Nov 19, 2014 Researchers Find a Way to Improve Memory by Suppressing a Molecule That Links Aging to Alzheimer's Disease. Journal of Neuroscience, Nov 12, 2014 http://www.newswise.com/articles/view/626415/?sc=mwtn
- ↑ Ma T, Klann E. PERK: a novel therapeutic target for neurodegenerative diseases? Alzheimers Res Ther. 2014 May 29;6(3):30. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25031640
- ↑ 5.0 5.1 5.2 Stutzbach LD1, Xie SX, Naj AC et al The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol Commun. 2013 Jul 6;1(1):31. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24252572